Ipsen Advisor Group LLC Bristol Myers Squibb CO Transaction History
Ipsen Advisor Group LLC
- $117 Billion
- Q4 2024
A detailed history of Ipsen Advisor Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ipsen Advisor Group LLC holds 9,381 shares of BMY stock, worth $505,635. This represents 0.45% of its overall portfolio holdings.
Number of Shares
9,381
Previous 6,552
43.18%
Holding current value
$505,635
Previous $471 Million
12.55%
% of portfolio
0.45%
Previous 0.54%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...